Search - tctmd.com

Displaying 141 - 160 of 303

Sort: Relevancy | Date

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

Presenter: Geraud Souteyrand

October 14, 2020

Presentation TCT 2020

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Hashrul Rashid

October 14, 2020

Presentation TCT 2020

TCT 450: Meta-Analysis of Device Related Thrombosis After Left Atrial Appendage Occlusion in Women Versus Men

Presenter: Yasir Abdul Ghaffar

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Daily News

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Caitlin E. Cox

September 23, 2020

News Daily News

Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA

L.A. McKeown

August 26, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Todd Neale

July 31, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

Shelley Wood

July 02, 2020

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2020

Shelley Wood

June 04, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Advertisement

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 459: Transcatheter Aortic Valve Thrombosis: Data From a French Multicenter Cohort Analysis

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

TCT 450: Meta-Analysis of Device Related Thrombosis After Left Atrial Appendage Occlusion in Women Versus Men

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

October 2020 News Roundup

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

TCTMD’s Top 10 Most Popular Stories for June 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

TCTMD’s Top 10 Most Popular Stories for May 2020

TCTMD’s Top 10 Most Popular Stories for April 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content